Modulation of iNOS activity in age-related cardiac dysfunction

Life Sciences

Volumn 75, Issue 6, 2004, Pages 655-667

  Yang, Bo ^a   Larson, Douglas F ^a   Watson, Ronald R ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Conductance catheter; Nitric oxide synthase; Ventricular function

Indexed keywords

AMINOGUANIDINE; ARGININE; INDUCIBLE NITRIC OXIDE SYNTHASE; METHYL ISOTHIOUREA; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; WILD TYPE;

AGING; ANIMALS; ARGININE; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GUANIDINES; ISOTHIURONIUM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; VENTRICULAR DYSFUNCTION, LEFT;

MITU;

EID: 2542494826     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.09.076     Document Type: Article

References (24)

1. Abdelaziz N., Colombo F., Mercier I., Calderone A. Nitric oxide attenuates the expression of transforming growth factor-beta(3) mRNA in rat cardiac fibroblasts via destabilization. Hypertension. 38(2):2001;261-266
2. Balligand J.L., Cannon P.J. Nitric oxide synthases and cardiac muscle. Autocrine and paracrine influences. Arteriosclerosis, Thrombosis, and Vascular Biology. 17(10):1997;1846-1858
3. Cernadas M.R., Sanchez D.M., Garcia-Duran M., Gonzalez-Fernandez F., Millas I., Monton M., Rodrigo J., Rico L., Fernandez P., de Frutos T., Rodriguez-Feo J.A., Guerra J., Caramelo C., Casado S., Lopez F. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circulation Research. 83(3):1998;279-286
4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Analytical Biochemistry. 162(1):1987;156-159
5. Colyer J. Phosphorylation states of phospholamban. Annuals of New York Academy of Sciences. 853:1998;79-91
6. Ferder L., Romano L.A., Ercole L.B., Stella I., Inserra F. Biomolecular changes in the aging myocardium: The effect of enalapril. American Journal of Hypertension. 11(11 Pt. 1):1998;1297-1304
7. Forstermann U., Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Naunyn-Schmiedeberg's Archives of Pharmacology. 352(4):1995;351-364
8. Haque R., Kan H., Finkel M.S. Effects of cytokines and nitric oxide on myocardial E-C coupling. Basic Research in Cardiology. 93(Suppl. 1):1998;86-94
9. Juilfs D.M., Soderling S., Burns F., Beavo J.A. Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs). Reviews of Physiology Biochemistry and Pharmacology. 135:1999;67-104
10. Kojda G., Kottenberg K., Nix P., Schluter K.D., Piper H.M., Noack E. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circulation Research. 78(1):1996;91-101
11. Lakatta E.G., Boluyt M.O. Age-Associated Changes in the Cardiovascular System in the Absence of Cardiovascular Disease. Hosenpud J.D., Greenberg B.H. Congestive Heart Failure. 2000;137-156 Lippincott Williams and Wilkins, Philadelphia
12. Lakatta E.G. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation. 107(3):2003;490-497
13. Lijnen P.J., Petrov V.V., Fagard R.H. Induction of cardiac fibrosis by transforming growth factor-beta(1). Molecular Genetics and Metabolism. 71(1-2):2000;418-435
14. Sanders D.B., Hunter K., Wu Y., Jablonowski C., Bahl J.J., Larson D.F. Modulation of the Inflammatory Response in the Cardiomyocyte and Macrophage. Journal of Extracorporeal Technology. 33:2001;167-174
15. Simmerman H.K., Jones L.R. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiological Reveiws. 78(4):1998;921-947
16. Stein B., Frank P., Schmitz W., Scholz H., Thoenes M. Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. Journal of Molecular and Cellular Cardiology. 28(8):1996;1631-1639
17. Szabolcs M.J., Ravalli S., Minanov O., Sciacca R.R., Michler R.E., Cannon P.J. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation. 65(6):1998;804-812
18. +-ATPase in skeletal muscle. Biochemical Journal. 340(Pt. 3):1999;657-669
19. Wildhirt S.M., Schulze C., Conrad N., Kornberg A., Horstman D., Reichart B. Aminoguanidine inhibits inducible NOS and reverses cardiac dysfunction late after ischemia and reperfusion-implications for iNOS-mediated myocardial stunning. Thoracic and Cardiovascular Surgery. 47(3):1999;137-143
20. Witte M.B., Barbul A. Role of nitric oxide in wound repair. American Journal of Surgery. 183(4):2002;406-412
21. Yang B., Larson D.F., Beischel J., Kelley R., Shi J., Watson R.R. Validation of Conductance Catheter System for Quantification of Murine Pressure-Volume Loops. Journal of Investigative Surgery. 14:2001;341-355
22. Yang B., Larson D.F., Watson R.R. Age-related left ventricular function in the mouse: analysis based on in vivo pressure-volume relationships. American Journal of Physiology. 277:1999;H1906-H1913
23. Yang B., Larson D.F., Kelley R., Beischel J., Watson R.R. Conductivity: An issue for the Application of the Conductance Catheter System in Mice. Cardiovascular Engineering. 5:2000;57-60
24. Zieman S.J., Gerstenblith G., Lakatta E.G., Rosas G.O., Vandegaer K., Ricker K.M., Hare J.M. Upregulation of the nitric oxide-cGMP pathway in aged myocardium: physiological response to l-arginine. Circulation Research. 88(1):2001;97-102